| Ytd | -2.65% | |
| 1y | 18.66% |
| Open | 105.83 | Prev Close | 106.60 | Low | 103.43 | High | 105.93 | Mkt Cap | 7.31B |
| Vol | 132.73K | Avg Vol | 802.97K | EPS | -3.13 | P/E | -34.06 | Forward P/E | -158.16 |
| Beta | 1.88 | Short Ratio | 9.81 | Inst. Own | 110.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 97.78 | 200-d Avg | 98.83 | 1yr Est | 139.73 |
RYTM News
NEW YORK, July 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inves
BOSTON, July 21, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global comm
NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a global commercial-stage biopharmaceutical company focu
BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global comm
RBC Capital analyst Lisa Walter maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Outperform
Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Positive Interim Results from Phase 2 Setmelanotide Tr
Rhythm Pharmaceuticals, Inc. (NASDAQ: RGPX) reported that setmelanotide therapy produced robust, sus
BOSTON, June 15, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global comm
Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock is trading higher on Monday after the company report
-- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or
BOSTON, June 12, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global comm
Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Goldman Sachs 47th Annual Global Healthcare Conferen
Rhythm Pharmaceuticals is transitioning from a development stage to a commercial rare disease leader
BOSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global comme
BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global comme
BOSTON, May 26, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global comme
Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Bank of America Global Healthcare Conference 2026 Tr
– Real world data showed clinically meaningful BMI reductions with setmelanotide in 62 adults with 1
Forget "sell in May and go away." These stocks are good picks to buy and hold.
Rhythm Pharmaceuticals (NASDAQ:RYTM) reported better-than-expected first-quarter financial results o
Playboy (PLBY) shares rise in pre-market trading after reporting better-than-expected Q4 results. Ot
US stock futures down 0.1% as Microvast Holdings Inc reports weak earnings, shares dip 22.9%. Other
Rhythm Pharmaceuticals says EMANATE trial misses goals, despite BMI reduction signals and continued
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as t
On Friday, 209 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Wednesday